Clinical-Microbiomics A/S: Financial statements 2018
CVR: 37230634
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
Clinical-Microbiomics A/S (CVR 37230634) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 8,507,396 and a net result of DKK -482,947 compared with DKK -4,377,471 the year before. That is an increase of 498.3% compared with the year before. Equity in the 2018 report amounted to DKK -4,253,558. The company had 12 employees in the financial year.
- Gross Profit
- DKK 8,507,396
- Profit/Loss
- DKK -482,947
- Equity
- DKK -4,253,558
- Total Assets
- DKK 6,291,918
- Employees
- 12
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | 8.5 mio. | -483 t. | -4.3 mio. | 12 |
| 2017 | - | 1.4 mio. | -4.4 mio. | -3.8 mio. | 9 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
Clinical-Microbiomics A/S has published its annual report for 2017. Gross profit came to DKK 1,421,891, and the net result was DKK -4,377,471.
About Clinical-Microbiomics A/S
Clinical-Microbiomics A/S is a Danish company of the type Aktieselskab based in København Ø, founded in 2015. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named Clinical-Microbiomics ApS. The management consists of Anders Christian Neto de Sousa Grøn. The board consists of Manoj Nirmal Dadlani (chair), Bruce Harvey Grant, Caroline Popper and Isabelle Valerie de Cremoux. The company's owners include MANJIN ApS, VENDLER ApS and Health For Life Capital II Prima S.C.A. RAIF. The company has 32 employees (2026). In 2025, the company reported a gross profit of EUR 2,831,000 and a net result of EUR -2,586,000 compared with EUR -4,328,000 the year before. Equity in the 2025 report amounted to EUR 85,447,000.